Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HEXO Corp. stock logo
HEXO
HEXO
C$0.00
C$0.85
C$4.97
C$38.72M2.13253,024 shs72,643 shs
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$3.84
+4.1%
C$4.14
C$3.56
C$5.77
C$114.15M-0.17865127,344 shs36,505 shs
I
Intellipharmaceutics International
C$0.00
C$1.78
C$4.50
C$97.40MN/A16,872 shs7,625 shs
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
C$0.79
+777.8%
C$0.79
C$0.30
C$2.06
C$111.69MN/A1.71 million shs56,653 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
+4.07%-1.54%-6.57%-15.60%-26.86%
I
Intellipharmaceutics International
0.00%0.00%0.00%0.00%0.00%
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HEXO Corp. stock logo
HEXO
HEXO
C$0.00
C$0.85
C$4.97
C$38.72M2.13253,024 shs72,643 shs
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$3.84
+4.1%
C$4.14
C$3.56
C$5.77
C$114.15M-0.17865127,344 shs36,505 shs
I
Intellipharmaceutics International
C$0.00
C$1.78
C$4.50
C$97.40MN/A16,872 shs7,625 shs
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
C$0.79
+777.8%
C$0.79
C$0.30
C$2.06
C$111.69MN/A1.71 million shs56,653 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
+4.07%-1.54%-6.57%-15.60%-26.86%
I
Intellipharmaceutics International
0.00%0.00%0.00%0.00%0.00%
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HEXO Corp. stock logo
HEXO
HEXO
0.00
N/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
3.50
Strong BuyC$8.00108.33% Upside
I
Intellipharmaceutics International
0.00
N/AN/AN/A
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest HEXO, HLS, MGW, and I Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2026
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
UpgradeOutperformStrong-BuyC$7.00 ➝ C$8.00
8/13/2026
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
UpgradeHoldBuy
(Data available from 8/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HEXO Corp. stock logo
HEXO
HEXO
C$124.10M0.00N/A1.55C$3.24 per share0.00
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$56.24M2.11C$0.25 per share15.22C$1.76 per share2.18
I
Intellipharmaceutics International
N/AN/AN/AN/AN/AN/A
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HEXO Corp. stock logo
HEXO
HEXO
-C$273.18M-C$3.41N/AN/A-220.13%-106.39%-14.96%N/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-C$15.53M-C$0.27N/AN/AN/A-15.26%-14.39%-2.89%N/A
I
Intellipharmaceutics International
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest HEXO, HLS, MGW, and I Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
N/A-C$0.03N/A-C$0.04N/AC$14.67 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
N/A4.30%N/AN/AN/A
I
Intellipharmaceutics International
N/AN/AN/AN/AN/A
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HEXO Corp. stock logo
HEXO
HEXO
125.99
0.41
0.40
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
75.86
1.05
1.01
I
Intellipharmaceutics International
N/AN/AN/A
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
HEXO Corp. stock logo
HEXO
HEXO
7.57%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
6.09%
I
Intellipharmaceutics International
N/A
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
HEXO Corp. stock logo
HEXO
HEXO
69044.00 millionN/ANot Optionable
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
9130.94 millionN/ANot Optionable
I
Intellipharmaceutics International
1,06930.16 millionN/ANot Optionable
Maple Leaf Green World Inc. stock logo
MGW
Maple Leaf Green World
N/A141.37 millionN/ANot Optionable

Recent News About These Companies

Maple Leaf Green World Inc.
MAPLE LEAF GREEN WORLD INC
HEXO stock logo

HEXO TSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.

HLS Therapeutics stock logo

HLS Therapeutics TSE:HLS

C$3.84 +0.15 (+4.07%)
As of 08/25/2026 04:00 PM Eastern

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.

Intellipharmaceutics International TSE:I

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

Maple Leaf Green World stock logo

Maple Leaf Green World CVE:MGW

C$0.79 +0.70 (+777.78%)
As of 04/19/2018

Maple Leaf Green World Inc. (Maple Leaf) is focused on eco-agriculture and renewable energy in the environmental industry. The Company is seeking opportunities to obtain an Marijuana for Medical Purposes Regulation (MMPR) License from Health Canada and medical marijuana business in the State of California, the United States. The Company operates through the eco-agriculture segment. Maple Leaf, along with its subsidiary, is engaged in exploring opportunities for its eco-agriculture nursery business, including medical marijuana in Canada and the United States, and its renewable energy business in China. Golden State Green World LLC is the subsidiary of the Company. The Company has not generated any revenues.